PARISI, CLAUDIA
PARISI, CLAUDIA
An overview on molecular characterization of thymic tumors: Old and new targets for clinical advances
2021 Tateo V.; Manuzzi L.; Parisi C.; De Giglio A.; Campana D.; Pantaleo M.A.; Lamberti G.
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma
2020 Lamberti G.; Andrini E.; Sisi M.; Rizzo A.; Parisi C.; Di Federico A.; Gelsomino F.; Ardizzoni A.
Evolution of cystic airspaces lung lesions on immune checkpoint inhibition in non-small cell lung cancer
2020 Parisi C.; Lamberti G.; Zompatori M.; Gelsomino F.; Salvagni S.; Sperandi F.; Ardizzoni A.
Immunobiology of thymic epithelial tumors: Implications for immunotherapy with immune checkpoint inhibitors
2020 Tateo V.; Manuzzi L.; De Giglio A.; Parisi C.; Lamberti G.; Campana D.; Pantaleo M.A.
Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC
2022 Dall'Olio, Filippo G; Parisi, Claudia; Marcolin, Laura; Brocchi, Stefano; Caramella, Caroline; Conci, Nicole; Carpani, Giulia; Gelsomino, Francesco; Ardizzoni, Stefano; Marchese, Paola Valeria; Paccapelo, Alexandro; Grilli, Giada; Golfieri, Rita; Besse, Benjamin; Ardizzoni, Andrea
PD-1/PD-L1 inhibitor monotherapy or in combination with chemotherapy as upfront treatment for advanced NSCLC with PD-L1 expression ≥ 50%: Selecting the best strategy
2021 Di Federico A.; De Giglio A.; Parisi C.; Gelsomino F.; Ardizzoni A.
PO.8 COELIAC DISEASE MISDIAGNOSIS IN PATIENTS WITH COMMON VARIABLE IMMUNODEFICIENCY
2008 Fiorini, E.; Granito, A.; Parisi, C.; Fiorentino, M.; Piscaglia, M.; Fabbri, A.; Bianchi, F.B.; Volta, U.
Programmed Cell Death Protein-1 Inhibitors Versus Programmed Death-Ligand 1 Inhibitors in Addition to Chemotherapy for the First-Line Treatment of Advanced NSCLC: A Systematic Review and Meta-Analysis
2021 Di Federico A.; De Giglio A.; Parisi C.; Gelsomino F.; Boni L.; Ardizzoni A.
STK11/LKB1 and KEAP1 mutations in non-small cell lung cancer: Prognostic rather than predictive?
2021 Di Federico A.; De Giglio A.; Parisi C.; Gelsomino F.
The evolving landscape of immunotherapy in small-cell lung cancer: A focus on predictive biomarkers
2019 Gelsomino, Francesco; Lamberti, Giuseppe; Parisi, Claudia; Casolari, Laura; Melotti, Barbara; Sperandi, Francesca; Ardizzoni, Andrea